Politics

Zero psilocybin [mushroom] arrests in Denver first month after decriminalization

From 2016 to 2018, the Denver Police Department arrested about fifty people per year for psilocybin-related offenses. The Denver City Attorney’s Office is still analyzing the ballot language and will present its findings to law enforcement and the mayor’s office. “We’re set to hear expert input in coming weeks to understand what ‘personal use’ and ‘possession with…

READ MORE
Spirituality

Replication and extension of a model predicting response to psilocybin

Mental states of surrender or preoccupation at the time of ingestion explain variance in mystical or adverse psilocybin experiences. Mystical experiences relate to long-term positive change. The capacity to recognize this optimal preparatory mental state may benefit therapeutic use of psilocybin in clinical [and other] settings. Original Article (Springerlink):Replication and extension of a model predicting…

READ MORE
Psychology

Eating mushrooms isn’t [just] like smoking a joint

“Under legalization, you would have big companies not just making mushrooms available but aggressively marketing them to people, as we’re seeing with cannabis,” said Michael Pollan. Under decriminalization, Oakland police will now put enforcement down among its lowest priorities (which means it won’t be a priority at all), and the city is forbidden from prosecuting…

READ MORE
Politics

The heady, thorny journey to decriminalize… [psilocybin containing] mushrooms

How quickly is the push to decriminalize psilocybin progressing, exactly? So quickly that it’s even surprised psychedelics advocates. “The fact that it’s happening so fast is kind of amazing,” says Brad Burge, spokesperson for the Multidisciplinary Association for Psychedelic Studies (MAPS), which leads studies of psychedelic therapies, including the aforementioned MDMA trial. “Here we have…

READ MORE
Biography/Memoir

Pushes to make it easier to study [psilocybin-containing] mushrooms and other psychedelic drugs

Legislation [was introduced] on Friday, June 10, 2019 to remove a legal barrier that scientists say makes it unnecessarily difficult for them to study the medical benefits of psychedelic drugs like psilocybin and MDMA. “Academics and scientists report that provisions like this create [stigma] and insurmountable logistical hurdles to researching schedule I drugs,” the summary…

READ MORE